Population | Intervention | Comparator | Outcomes | Study Design | |
---|---|---|---|---|---|
Inclusion Criteria | Patient was diagnosed as IgAN by renal biopsy | low-dose corticosteroid plus leflunomide | full-dose corticosteroid | eGFR (ml/min/1.73m2). Serum creatinine. Urine protein excretion. Complete remission. Overall remission. Complications. | Clinical research |
Exclusion Criteria | Patients with rapidly progressive IgA nephropathy. Secondary IgA nephropathy due to the patient’s systemic illness. Patients with severe infections. Patients with Patients were on CS or other immunosuppressive therapy within 6 months before enrollment. Patients with malignancy, HIV infection, or acute central nervous system diseases. | Not performed | Not performed | Blood pressure. Hematuria. End-stage renal disease (ESRD). Acute kidney injury. Edema. | Letters, comments, reviews, qualitative studies |